Ask AI

Precision in Practice: A Master Class on PARPi Combinations, Testing Strategies, and Toxicity Management in Metastatic Prostate Cancer

Improve your understanding of current PARP inhibitor–based combination regimens for the management of metastatic prostate cancer based on key clinical evidence and guideline recommendations to enhance patient outcomes through a certified on-demand webcast, expert-written ClinicalThought commentary, and downloadable slides.

Share

Program Content

Activities

Biomarker Testing in Prostate Cancer
Best Practices for Integration of Biomarker and Genetic Mutation Testing in Clinical Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2026

PARPi Combinations in mPC
Evaluating the Data: The Rationale for PARPi Combinations
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2026

PARPi Safety in mPC
Mitigating AEs With PARPi Combinations: Optimizing Patient Quality of Life
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2026

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by an educational grant from AstraZeneca. Supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

AstraZeneca

Merck & Co., Inc., Rahway, NJ, USA

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner